• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

致癌机制研究(IX)——肝癌发生过程中增殖酶基因和组织特异性酶基因的差异表达

Studies on the mechanism of carcinogenesis (IX)--Differential expression of proliferating and tissue-specific enzyme genes during hepatocarcinogenesis.

作者信息

Wu S J, Li S E

机构信息

Faculty of Basic Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing.

出版信息

Sci Sin B. 1988 May;31(5):590-5.

PMID:3420396
Abstract

With cDNA fragments of CPS1, OCT and ACT as probes, dot and Northern blot analyses of poly(A)+-RNA from rat liver with different pathological lesions during carcinogenesis induced by diethylnitrosamine were conducted. It was shown that the level of mRNA of tissue-specific enzymes, CPSI and OCT decreased while that of the proliferating enzyme ACT mRNA increased, and the alteration was correlated with the degree of pathological changes in each case. The relative changes in the mRNA level of these enzymes during hepatocarcinogenesis were correlated with that of enzyme activities. Implication of these findings in the mechanism of carcinogenesis in terms of cell proliferation and differentiation was discussed.

摘要

以CPS1、OCT和ACT的cDNA片段为探针,对二乙基亚硝胺诱导致癌过程中大鼠肝脏不同病理损伤的poly(A)+ -RNA进行斑点杂交和Northern印迹分析。结果表明,组织特异性酶CPSI和OCT的mRNA水平降低,而增殖酶ACT的mRNA水平升高,且这种变化与每种情况下的病理变化程度相关。这些酶在肝癌发生过程中mRNA水平的相对变化与酶活性的变化相关。讨论了这些发现对细胞增殖和分化致癌机制的意义。

相似文献

1
Studies on the mechanism of carcinogenesis (IX)--Differential expression of proliferating and tissue-specific enzyme genes during hepatocarcinogenesis.致癌机制研究(IX)——肝癌发生过程中增殖酶基因和组织特异性酶基因的差异表达
Sci Sin B. 1988 May;31(5):590-5.
2
Cloning of cDNA coding for carbamyl phosphate synthetase I and changes in levels of CPS1 mRNA during hepatocarcinogenesis.编码氨甲酰磷酸合成酶I的cDNA克隆及肝癌发生过程中CPS1 mRNA水平的变化。
Sci Sin B. 1988 Feb;31(2):197-203.
3
Alteration in chromatin conformation of proliferating and differentiating enzyme genes in normal mouse liver and ascites hepatoma cells and its relation to the gene expression of enzymes.正常小鼠肝脏和腹水肝癌细胞中增殖和分化酶基因的染色质构象改变及其与酶基因表达的关系。
Sci Sin B. 1988 Nov;31(11):1319-24.
4
[Studies on the mechanism of carcinogenesis. VIII. Purification of ornithine carbamyl transferase in the rat liver and immunochemical titration of the enzyme during carcinogenesis].[致癌作用机制的研究。VIII. 大鼠肝脏中鸟氨酸氨甲酰基转移酶的纯化及致癌过程中该酶的免疫化学滴定]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1986 Aug;8(4):297-300.
5
Altered expression of cytochrome P450 mRNA during chemical-induced hepatocarcinogenesis and following partial hepatectomy.化学诱导肝癌发生过程中及部分肝切除术后细胞色素P450 mRNA表达的改变。
Toxicol Appl Pharmacol. 1994 Jan;124(1):139-48. doi: 10.1006/taap.1994.1017.
6
[The inhibitory effects of epicatechin complex on diethylnitrosamine induced initiation of hepatocarcinogenesis in rats].
Zhonghua Yu Fang Yi Xue Za Zhi. 1993 Jul;27(4):201-4.
7
[Studies on the mechanism of carcinogenesis. V. Differential changes in activities of enzymes involved in ornithine metabolism in early phase of hepatocarcinogenesis induced by diethylnitrosamine].[致癌作用机制的研究。V. 二乙基亚硝胺诱导的肝癌发生早期鸟氨酸代谢相关酶活性的差异变化]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 1982 Jun;4(3):141-6.
8
[Comparative systemic analysis of experimental models of chemical hepatic carcinogenesis in the rat].[大鼠化学性肝癌发生实验模型的比较系统分析]
C R Seances Soc Biol Fil. 1984;178(4):397-407.
9
mRNA levels of catalytic subunits of protein phosphatases 1, 2A, and 2C in hepatocarcinogenesis.蛋白磷酸酶1、2A和2C催化亚基在肝癌发生过程中的mRNA水平
Jpn J Cancer Res. 1992 Jan;83(1):66-71. doi: 10.1111/j.1349-7006.1992.tb02353.x.
10
Changes in aldehyde dehydrogenase activity during diethylnitrosamine- or 2-acetylaminofluorene-initiated rat hepatocarcinogenesis.在二乙基亚硝胺或2-乙酰氨基芴引发的大鼠肝癌发生过程中醛脱氢酶活性的变化
Cancer Res. 1983 Apr;43(4):1710-5.